Lipoprotein(a) and aortic diseases: Epidemiological evidence from observation to causation
Journal of Clinical Lipidology · 2026-09 · 20 (9) · 1978-1987
DOI: 10.1016/j.jacl.2026.07.014 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Lipidology, 2026-09. Verfasst von Dexiang Xia und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Vascular Surgery, the Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, China (Xia, Zhang, Fang, Shu, J. Li, a…. Hauptthemen laut MEDLINE: Lipoprotein(a), Aortic Aneurysm, Aortic Diseases. Die Arbeit nennt 25 Literaturangaben. Gefördert von: Central South University, National Natural Science Foundation of China, Natural Science Foundation of Hunan Province.
Abstract (Originalsprache)
BACKGROUND: Aortic aneurysm and dissection (AA/AD) are life-threatening vascular diseases with high mortality, yet no effective drugs to delay progression. Lipoprotein(a) [Lp(a)] is genetically determined and associated with atherosclerotic disease, but high-quality evidence on its causal role in AA/AD remains limited. OBJECTIVE: To investigate the association between Lp(a) and AA/AD and assess potential causal relationships with major aortic disease subtypes. METHODS: A prospective cohort of 312,332 UK Biobank participants was analyzed. Kaplan-Meier curves, Cox regression, and Fine-Gray competing-risk models assessed associations between Lp(a) and incident AA/AD. Two-sample Mendelian randomization (MR) analyses evaluated the potential causal effects of Lp(a) on AA, abdominal aortic aneurysm (AAA), thoracic aortic aneurysm (TAA), and AD. RESULTS: During a median follow-up of 16.5 years, 3122 AA/AD events occurred. Elevated Lp(a) independently predicted AA/AD with a dose-response relationship (hazard ratio [HR] = 1.40 for >180 vs
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Vascular Surgery, the Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, China (Xia, Zhang, Fang, Shu, J. Li, and X. Li); The Institute of Vascular Diseases, Central South Universit…
- Department of Urology, the Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, China (Hu).
- Molecular Biology Research Center, School of Life Sciences, Hunan Province Key Laboratory of Basic and Applied Hematology, Central South University, Changsha, Hunan 410013, China (M. Li).
- Department of Cardiovascular Medicine, the Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, China (Chen).
Förderung
- Central South University
- National Natural Science Foundation of China
- Natural Science Foundation of Hunan Province
Zitieren
APA
Xia, D., Zhang, L., Fang, J., Hu, W., Li, M., Chen, Y., Shu, C., Li, J., & Li, X. (2026). Lipoprotein(a) and aortic diseases: Epidemiological evidence from observation to causation. Journal of Clinical Lipidology, 20(9), 1978-1987. https://doi.org/10.1016/j.jacl.2026.07.014
Vancouver
Xia D, Zhang L, Fang J, Hu W, Li M, Chen Y, et al. Lipoprotein(a) and aortic diseases: Epidemiological evidence from observation to causation. Journal of Clinical Lipidology. 2026;20(9):1978-1987. doi:10.1016/j.jacl.2026.07.014
BibTeX
@article{Xia2026,
author = {Xia, Dexiang and Zhang, Lei and Fang, Junjie and Hu, Wentao and Li, Maohua and Chen, Yunfan and Shu, Chang and Li, Jiehua and Li, Xin},
title = {Lipoprotein(a) and aortic diseases: Epidemiological evidence from observation to causation},
journal = {Journal of Clinical Lipidology},
year = {2026},
volume = {20},
number = {9},
pages = {1978--1987},
doi = {10.1016/j.jacl.2026.07.014}
}
EUVIMED